Trial Profile
Bone Resorption, Osteoclastogenesis and Adalimumab.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms BROCA
- 28 Jan 2009 New trial record